PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Discovery could help reverse glucocorticoid resistance in some young leukemia patients

St. Jude Children's Research Hospital study lays the foundation for more effective treatment of childhood leukemia and a wide range of other disorders using small molecules to reverse glucocorticoid resistance

2015-05-04
(Press-News.org) (MEMPHIS, Tenn. -- May 4, 2015) Researchers led by St. Jude Children's Research Hospital scientists have identified a mechanism that helps leukemia cells resist glucocorticoids, a finding that lays the foundation for more effective treatment of cancer and possibly a host of autoimmune diseases. The findings appear online today in the scientific journal Nature Genetics.

The research focused on glucocorticoids, a class of steroid hormones. These hormones have been key ingredients in the chemotherapy cocktail that has helped to push long-term survival for the most common childhood cancer to 85 percent nationwide and about 94 percent at St. Jude. Young acute lymphoblastic leukemia (ALL) patients whose cancer is resistant to steroids are less likely to survive. Yet the cause of resistance is often unknown.

In this study, scientists identified a mechanism responsible for about one-third of steroid resistance in children and adolescents with ALL. Additional research is needed to determine if the process is at work in adults with ALL, where steroid resistance is more common and long-term survival lags.

"Based on these findings, research has already begun to identify small molecules with the potential to reverse glucocorticoid resistance, leading to more effective treatment and increased survival," said the paper's corresponding author, William Evans, Pharm.D., a member of the St. Jude Department of Pharmaceutical Sciences. "Glucocorticoids are widely used to treat asthma, rheumatoid arthritis, colitis and other autoimmune disorders. That means these results have the potential to benefit a wide range of patients."

The study included bone marrow cells from 444 newly identified ALL patients being treated at St. Jude or in the clinical trials sponsored by the Dutch Childhood Oncology Group and the German Cooperative Study Group for Childhood ALL. Cells also were collected at diagnosis and relapse from 49 pediatric ALL patients enrolled in clinical trials organized by the Children's Oncology Group.

By searching across the genome, researchers identified differences in gene activity or expression in leukemia cells that were either sensitive to or resistant to steroids. Caspase 1 (CASP1) and NLRP3 were among the genes with increased activity in steroid-resistant cells. NLRP3 makes a protein that switches on or activates CASP1.

Researchers also identified one reason for the increased gene activity. Cells can lock genes in the "off" position by adding methyl groups to DNA using a process called methylation. Leukemia cells over-expressing CASP1 and NLRP3 had lower levels of methylation compared to cells with normal expression.

Previous research had shown that steroid resistance was more common in young ALL patients who relapsed than in new patients. Investigators in this study checked CASP1 and NLRP3 expression in the ALL patients who relapsed and found expression of both genes was significantly higher.

Glucocorticoids kill cancer cells by regulating the activity of certain genes, including genes that control the cell's apoptotic or suicide pathway. To work, the drugs must bind to glucocorticoid receptors in the liquid interior of cells. The receptors then ferry the drug into the cell nucleus where the steroid and receptors work together to regulate gene activity by binding to DNA.

Researchers discovered that CASP1 blocks glucocorticoids by splitting the receptor where the drug binds and so blocks its access to the nucleus. "Cells that over-express CASP1 are chewing up their glucocorticoid receptor," Evans said. "That means when steroids enter the cell, there is no receptor for the drugs to bind to or fulfill its therapeutic function."

To confirm that CASP1 cleavage of the steroid receptor was pivotal to ALL steroid resistance, researchers engineered a receptor that lacked the CASP1 cleavage site. When they introduced the genetically engineered receptors into ALL cells that expressed high levels of CASP1, the cells remained sensitive to steroids.

Using a variety of techniques, researchers showed that steroid resistance rose or fell in leukemia cells based on CASP1 levels. Over-expression of CASP1 rendered ALL cells five to 15 times more resistant to the glucocorticoids dexamethasone and prednisolone. Both drugs are used at St. Jude to treat ALL.

Researchers showed that reducing CASP1 using genetic, pharmacological or other methods restored steroid sensitivity in leukemia cells.

INFORMATION:

The first author is Steven Paugh, Ph.D., a postdoctoral fellow in Evans' laboratory. The other authors are Erik Bonten, Laura Ramsey, Prajwal Gurung, R.K. Subbarao Malireddi, Marcelo Actis, Anand Mayasundari, Jaeki Min, John Panetta, J. Robert McCorkle, Yiping Fan, Kristine Crews, Mark Wilkinson, Cheng Cheng, Wenjian Yang, Seth Karol, Christian Fernandez, Barthelemy Diouf, Colton Smith, Charles Mullighan, Sima Jeha, Ching-Hon Pui, R. Kiplin Guy, Thirumala-Devi Kanneganti and Mary Relling, all of St. Jude; William Thierfelder, David Coss, Lucas Laudermilk, Gabriele Stocco, Antonio Ferreira, J. Kevin Hicks, Alessandra Zanut, Audrey Giordanengo, Daniel Crona, Joy Bianchi, Linda Holmfeldt and Deepa Bhojwani, all formerly of St. Jude; Daniel Savic and Richard Myers, both of HudsonAlpha Institute for Biotechnology, Huntsville, Ala.; Monique denBoer, Erasmus University Medical Center, Rotterdam, the Netherlands; Rob Pieters, Erasmus University and Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands; Thomas Dunwell and Farida Latif, University of Birmingham, UK; and William Carroll, New York University Langone Medical Center, New York.

The research was funded in part by grants (CA36401, GM92666, CA141762, CA21765) from the National Institutes of Health; the American Recovery and Reinvestment Act supplement; and ALSAC.

St. Jude Media Relations Contacts

Carrie Strehlau
Desk: (901) 595-2295
Cell: (901) 297-9875
carrie.strehlau@stjude.org

Summer Freeman
Desk: (901) 595-3061
Cell: (901) 297-9861
summer.freeman@stjude.org

St. Jude Children's Research Hospital

St. Jude Children's Research Hospital is leading the way the world understands, treats and defeats childhood cancer and other life-threatening diseases. It is the only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20 percent to 80 percent since the hospital opened more than 50 years ago. St. Jude is working to increase the overall survival rate for childhood cancer to 90 percent in the next decade. St. Jude freely shares the breakthroughs it makes, and every child saved at St. Jude means doctors and scientists worldwide can use that knowledge to save thousands more children. Families never receive a bill from St. Jude for treatment, travel, housing and food--because all a family should worry about is helping their child live. To learn more, visit stjude.org or follow St. Jude at @stjuderesearch.



ELSE PRESS RELEASES FROM THIS DATE:

Scientists dramatically improve method for finding common genetic alterations in tumors

2015-05-04
(MEMPHIS, Tenn. - May 4, 2015) St. Jude Children's Research Hospital scientists have developed a significantly better computer tool for finding genetic alterations that play an important role in many cancers but were difficult to identify with whole-genome sequencing. The findings appear today in the scientific journal Nature Methods. The tool is an algorithm called CONSERTING, short for Copy Number Segmentation by Regression Tree in Next Generation Sequencing. St. Jude researchers created CONSERTING to improve identification of copy number alterations (CNAs) in the ...

Detecting knee-cushion problems early could lead to better treatments

Detecting knee-cushion problems early could lead to better treatments
2015-05-04
COLUMBIA, Mo. -- Within the knee, two specialized, C-shaped pads of tissue called menisci perform many functions that are critical to knee-joint health. The menisci, best known as the shock absorbers in the knee, help disperse pressure, reduce friction and nourish the knee. Now, new research from the University of Missouri shows even small changes in the menisci can hinder their ability to perform critical knee functions. The research could provide new approaches to preventing and treating meniscal injuries as well as clues to understanding osteoarthritis; meniscal problems ...

3-D printed trachea among key Mount Sinai research presented at AATS meeting

2015-05-04
(New York -- May 4, 2015) Icahn School of Medicine at Mount Sinai researchers presented several landmark studies at the 2015 American Association for Thoracic Surgery (AATS) meeting in Seattle. AATS Highlights include: First Successful 3D Printed Trachea A team of researchers from Icahn School of Medicine have combined 3D printing technology with human stem cells to create the first successful 3D-printed biologic tracheal graft in an animal model. Using a biocompatible polymer, researchers created a customized 3D-printed tracheal graft seeded with stem cells. The ...

Global decline of large herbivores may lead to an 'empty landscape'

Global decline of large herbivores may lead to an empty landscape
2015-05-04
CORVALLIS, Ore. - The decline of the world's large herbivores, especially in Africa and parts of Asia, is raising the specter of an "empty landscape" in some of the most diverse ecosystems on the planet, according to a newly published study. Many populations of animals such as rhinoceroses, zebras, camels, elephants and tapirs are diminishing or threatened with extinction in grasslands, savannahs, deserts and forests, scientists say. An international team of wildlife ecologists led by William Ripple, Oregon State University distinguished professor in the College of ...

Inanimate beads behave in lifelike ways

2015-05-04
Scientists have created microbe-sized beads that can utilize energy in the environment to self-propel upstream by purely physical means. Life is hard to define, but metabolism, mobility and replication are three commonly agreed elements. The beads are not alive, but they meet two of these three requirements. "Living systems change their behavior according to their environment," said Jeremie Palacci, a professor of physics at the University of California, San Diego. "So the question was, can we design a particle that can sense its environment with no neural system or ...

Beyond chicken fingers and fries: New evidence in favor of healthier kids' menus

2015-05-04
Contrary to popular belief, more healthy kids' meals were ordered after a regional restaurant chain added more healthy options to its kids' menu and removed soda and fries, researchers from ChildObesity180 at Tufts University Friedman School reported today in the journal Obesity. Including more healthy options on the menu didn't hurt overall restaurant revenue, and may have even supported growth. Researchers examined outcomes before and after the Silver Diner, a full-service family restaurant chain, made changes to its children's menu in order to make healthier items ...

Off-label use of device to prevent stroke in a-fib patients is prevalent, potentially dangerous

2015-05-04
PHILADELPHIA - The Lariat device, which has been cleared by the U.S. Food and Drug Administration (FDA) for soft tissue approximation (placement of a suture) during surgical procedures, is associated with a significant incidence of death and urgent cardiac surgery during its frequent off-label use to prevent stroke in patients with the irregular heartbeat known as atrial fibrillation. Following a systematic review of case reports and an FDA safety database, researchers at the Perelman School of Medicine at the University of Pennsylvania are calling for formal controlled ...

Kids likely to sleepwalk if parents have history of nocturnal strolls

2015-05-04
More than 60 percent of children developed sleepwalking when both their parents were sleepwalkers in a study among children born in the Canadian province of Quebec, according to an article published online by JAMA Pediatrics. Sleepwalking is a common childhood sleep disorder that usually disappears during adolescence, although it can persist or appear in adulthood. Sleep terrors are another early childhood sleep disorder often characterized by a scream, intense fear and a prolonged period of inconsolability. The two disorders (also known as parasomnias) share many of ...

Study examines incidence of concussion in youth, high school, college football

2015-05-04
A slight majority of concussions happened during youth football games but most concussions at the high school and college levels occurred during practice, according to an article published online by JAMA Pediatrics. Football is a popular youth sport with approximately 3 million youth athletes, 1.1 million high school athletes and 100,000 college athletes playing tackle football each year. A report on concussion by the Institute of Medicine highlighted the need for more extensive data on incidence in athletes from youth to college. Thomas P. Dompier, Ph.D., A.T.C., of ...

School competitive food policies appears tied to neighborhood socioeconomics

2015-05-04
Policy changes in California to make the food and beverages that compete with school meal programs more healthy for students appear to have improved childhood overweight/obesity prevalence trends, although improvement was better among students attending schools in socioeconomically advantaged neighborhoods, according to an article published online by JAMA Pediatrics. Many school districts have adopted policies to regulate so-called competitive food and beverages (CF&Bs) because of childhood obesity. California has enacted among the most comprehensive CF&B policies in ...

LAST 30 PRESS RELEASES:

Andrew E. Place, MD, PhD appointed as Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Vice President, Pediatric Chief Medical Officer

COVID-19 antibody discovery could explain long COVID

Wild plants face viral surprise

Storing electrons from hydrogen for clean chemical reactions

Unlocking how to use mRNA to target Alzheimer’s disease

Kessler Foundation secures $770,000 in grants to advance leading-edge spinal cord research

Going ‘back to the future’ to forecast the fate of a dead Florida coral reef

How extratropical ocean-atmosphere interactions can contribute to the variability of jet streams in the Northern Hemisphere

MSK Research Highlights, March 28, 2024

USDA, Nueta Hidatsa Sahnish College collaborate to support Indigenous Seed Sovereignty

For younger women, mental health now may predict heart health later

Missed opportunity: AEDs near cardiac arrests rarely used by bystanders

Eggs may not be bad for your heart after all

Alcohol raises heart disease risk, particularly among women

TTUHSC announces new center for nursing research

Adding just enough fuel to the fire

Impact of synbiotic supplements on the gut microbiome and overall health of penguins

Promising advances in organosilica membranes for separating organic liquid mixtures

Cell phone video technology unveils new method for analyzing walking and gait

Ancient isolation’s impact on modern ecology

Synaptic protein change during development offers clues on evolution and disease

How commercial rooftop solar power could bring affordable clean energy to low-income homes

Taking a closer look at pulmonary fibrosis genetics

Cats with MDR1 mutation at risk of severe reactions to popular medication

IOP Publishing and IPEM mandate reporting of sex and gender in research 

Dogs trained to detect trauma stress by smelling humans’ breath

Electronic device thermal management made simpler and slightly better!

Study: Dangerous surgical site infections can be reduced with simple prevention protocol

Genetic testing of patients with atrial fibrillation can alert clinicians to potential development of life-threatening conditions

Artificial Intelligence tool successfully predicts fatal heart rhythm

[Press-News.org] Discovery could help reverse glucocorticoid resistance in some young leukemia patients
St. Jude Children's Research Hospital study lays the foundation for more effective treatment of childhood leukemia and a wide range of other disorders using small molecules to reverse glucocorticoid resistance